Nurse Anesthetist - CR in Davenport, IA Accepting Medicare
7 Nurse Anesthetist - CR nurses found. Showing 1 - 7
 Tara M Kinney, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 3400 Dexter Ct Ste 104, Davenport, IA 52807 Phone: 563-334-0234 Fax: 563-334-0235 |
Julie A Ridgley, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 3400 Dexter Ct, Suite 101, Davenport, IA 52807 Phone: 563-344-6600 Fax: 563-344-6699 |
Dr. Laura Ann Holst, DNP, ANESTHESIA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1227 E Rusholme St, Davenport, IA 52803 Phone: 563-324-8160 |
 Timothy P Newcomb, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 3400 Dexter Ct, Suite 101, Davenport, IA 52807 Phone: 563-344-6600 Fax: 563-344-6699 |
Mrs. Dana Sue Coffman, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 3400 Dexter Ct, Suite 101, Davenport, IA 52807 Phone: 563-344-6746 Fax: 563-344-6740 |
Sarah A Butcher, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 3400 Dexter Ct, Davenport, IA 52807 Phone: 563-344-6600 |
Mrs. Connie Colleen Mykleby, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1227 East Rusholme Street, Davenport, IA 52803 Phone: 563-421-1000 Fax: 563-421-7889 |
News Archive
Amgen submits BLA for denosumab subcutaneous RANK Ligand inhibitor
Amgen Inc. today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for denosumab, a subcutaneous RANK Ligand inhibitor. The BLA submission summarizes clinical experience from nearly 6,900 patients across 18 clinical studies, including approximately 5,700 patients with advanced cancer in the three, pivotal, Phase 3, head-to-head trials versus Zometa® (zoledronic acid).
AARP says bipartisan amendment can bring down medication costs
The U.S. Senate today rejected an amendment to the Patient Protection and Affordable Care Act that would have helped make prescription drugs more affordable by allowing for the safe and legal importation of lower priced drugs from abroad. The bipartisan amendment, endorsed by AARP and sponsored by Senators Dorgan, Snowe, McCain, Grassley and Stabenow, would have improved competition and helped to bring down the skyrocketing costs of prescription drugs.
USAID has technical capacity to lead GHI if given authority
In a post in the Center for Global Development's "Rethinking U.S. Foreign Assistance Blog," Nandini Oomman, director of the HIV/AIDS Monitor at the center, and Rachel Silverman, a research assistant at the center, examine the question of Global Health Initiative (GHI) leadership, citing the State Department's Quadrennial Diplomacy and Development Review (QDDR), released last December, which states that "USAID would assume leadership of the GHI by September 2012, contingent upon fulfilling a set of 10 benchmarks to demonstrate its capacity."
Inovio to use proceeds from $24.3M offering for development of DNA vaccine against cervical dysplasias
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the closing of the sale to a single institutional investor of 21,130,400 shares of its common stock and warrants to purchase up to 10,565,200 additional shares of its common stock.
› Verified 1 days ago